Enid R Neptune
Overview
Explore the profile of Enid R Neptune including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
2136
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Romero M, Yue Q, Ahn W, Hamacher J, Zaidi Y, Haigh S, et al.
Am J Respir Cell Mol Biol
. 2024 Oct;
PMID: 39405473
Infection of lung endothelial cells with pneumococci activates the superoxide-generating enzyme NADPH oxidase 2 (NOX2), involving the pneumococcal virulence factor pneumolysin (PLY). Excessive NOX2 activity disturbs capillary barriers, but its...
2.
Unveiling the Tobacco Industry's Exploitative Legacy: A Call for Racial Equity through a Menthol Ban
Kathuria H, Ewart G, Neptune E, Upson D
Ann Am Thorac Soc
. 2024 Aug;
21(9):1245-1246.
PMID: 39212422
No abstract available.
3.
Benjamin K, Sauler M, Poonyagariyagorn H, Neptune E
bioRxiv
. 2024 Jul;
PMID: 38948835
The renin-angiotensin system is a highly characterized integrative pathway in mammalian homeostasis whose clinical spectrum has been expanded to lung disorders such as chronic obstructive pulmonary disease (COPD)-emphysema, idiopathic pulmonary...
4.
5.
Loube J, Gidner S, Venezia J, Ryan H, Neptune E, Mitzner W, et al.
Am J Physiol Lung Cell Mol Physiol
. 2023 Aug;
325(4):L500-L507.
PMID: 37643013
The clinical definition of "difficult asthma" has expanded recently to include an ever-growing subset of patients with symptoms that cannot be controlled by conventional means, forcing the medical community to...
6.
Rebuli M, Rose J, Noel A, Croft D, Benowitz N, Cohen A, et al.
Ann Am Thorac Soc
. 2022 Dec;
20(1):1-17.
PMID: 36584985
E-cigarette or vaping product use-associated lung injury (EVALI) is a severe pulmonary illness associated with the use of e-cigarettes or vaping products that was officially identified and named in 2019....
7.
Neptune E
Pediatr Allergy Immunol Pulmonol
. 2022 Aug;
24(2):119-125.
PMID: 35927882
The complex disorders of chronic obstructive pulmonary disease (COPD) and bronchopulmonary dysplasia (BPD) are common, costly, and clinically burdensome. Both lung disorders develop after complex injurious triggers and can result...
8.
Wise R, Holbrook J, Brown R, Criner G, Dransfield M, He J, et al.
Am J Respir Crit Care Med
. 2022 Jun;
206(7):838-845.
PMID: 35649189
There are no pharmacologic agents that modify emphysema progression in patients with chronic obstructive pulmonary disease (COPD). To evaluate the efficacy of losartan, an angiotensin receptor blocker, to reduce emphysema...
9.
Wilson A, Chiles J, Ashish S, Chanda D, Kumar P, Mobley J, et al.
Sci Rep
. 2022 Feb;
12(1):3080.
PMID: 35197532
Fibrosis is a leading cause of morbidity and mortality worldwide. Although fibrosis may involve different organ systems, transforming growth factor-β (TGFβ) has been established as a master regulator of fibrosis...
10.
Sowho M, MacCarrick G, Dietz H, Jun J, Schwartz A, Neptune E
BMJ Open Respir Res
. 2021 Nov;
8(1).
PMID: 34782328
Background: Marfan syndrome (MFS) is a connective tissue disorder characterised by complex aortic pathology and a high prevalence of obstructive sleep apnoea (OSA). OSA produces intrathoracic transmural stresses that may...